United States Ponatinib Mono-hydrochloride Market by Application Ponatinib mono-hydrochloride, a potent tyrosine kinase inhibitor, is gaining prominence in the United States pharmaceutical market, primarily due to its efficacy in treating certain types of cancers, notably chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Its mechanism of action involves targeting […]
Recent News